Literature DB >> 21891774

Circulating microRNA expression is reduced in chronic kidney disease.

Calida S Neal1, Michael Z Michael, Letitia K Pimlott, Tuck Y Yong, Jordan Y Z Li, Jonathan M Gleadle.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) are important regulators of gene expression, which have roles in renal development and disease. They exist in biological fluids including blood and urine and may have signalling roles and potential as disease biomarkers.
METHODS: We measured the levels of miRNAs in patients with different stages of chronic kidney failure including those receiving maintenance haemodialysis treatment.
RESULTS: In patients with severe chronic renal failure, circulating levels of total and specific miRNAs are reduced in comparison to patients with mild renal impairment or normal renal function. A strong correlation exists between detected circulating miRNAs and estimated glomerular filtration rate, and less strong correlations with other features of chronic kidney disease, such as anaemia and hyperparathyroidism.
CONCLUSION: These findings have important implications for the use of circulating miRNAs as biomarkers in individuals with renal impairment and for the pathogenesis of uraemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21891774     DOI: 10.1093/ndt/gfr485

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  85 in total

1.  Circulating and renal vein levels of microRNAs in patients with renal artery stenosis.

Authors:  Moo Yong Park; Sandra M Herrmann; Ahmed Saad; Robert Jay Widmer; Hui Tang; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2014-10-31       Impact factor: 5.992

2.  Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.

Authors:  Amaryllis H Van Craenenbroeck; Kristien J Ledeganck; Katrijn Van Ackeren; Angelika Jürgens; Vicky Y Hoymans; Erik Fransen; Volker Adams; Benedicte Y De Winter; Gert A Verpooten; Christiaan J Vrints; Marie M Couttenye; Emeline M Van Craenenbroeck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

Review 3.  MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

Review 4.  Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma.

Authors:  Michela Bottani; Giuseppe Banfi; Giovanni Lombardi
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

Review 5.  Noninvasive micromarkers.

Authors:  Janani Saikumar; Krithika Ramachandran; Vishal S Vaidya
Journal:  Clin Chem       Date:  2014-01-09       Impact factor: 8.327

6.  Detection of dietary plant-based small RNAs in animals.

Authors:  Jian Yang; Lisa M Farmer; Abia A A Agyekum; Kendal D Hirschi
Journal:  Cell Res       Date:  2015-02-27       Impact factor: 25.617

Review 7.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 8.  Genomic approaches in the search for molecular biomarkers in chronic kidney disease.

Authors:  M Cañadas-Garre; K Anderson; J McGoldrick; A P Maxwell; A J McKnight
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

9.  Effects of a 28-day dietary co-exposure to melamine and cyanuric acid on the levels of serum microRNAs in male and female Fisher 344 rats.

Authors:  Camila S Silva; Ching-Wei Chang; Denita Williams; Patricia Porter-Gill; Gonçalo Gamboa da Costa; Luísa Camacho
Journal:  Food Chem Toxicol       Date:  2016-09-09       Impact factor: 6.023

10.  MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.

Authors:  Claudia Goettsch; Joshua D Hutcheson; Elena Aikawa
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.